Interleukin-1 was initially identified as an osteoclast activating factor and is a highly pro-inflammatory cytokine
The synergy argument is that BPC-157 improves the local healing environment (better blood flow, more growth factors, reduced harmful inflammation) while TB-500 enhances the cellular repair process itself (more repair cells arriving, better cell mobility, less scarring)
Visible degradation signs include color changes (yellowing), cloudiness in reconstituted solution, particulate matter, or visible precipitation
First, rib injuries rarely involve bone damage alone
The actual milligram dose depends entirely on your reconstitution concentration
Colonoscopy, mammography, Pap smears, PSA testing, and skin examinations as appropriate for age and risk factors detect cancers early when treatment is most effective